Motif ID: Gtf2i_Gtf2f1
Z-value: 1.556
Transcription factors associated with Gtf2i_Gtf2f1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Gtf2f1 | ENSMUSG00000002658.9 | Gtf2f1 |
| Gtf2i | ENSMUSG00000060261.9 | Gtf2i |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Gtf2i | mm10_v2_chr5_-_134314678_134314760 | -0.48 | 8.1e-06 | Click! |
| Gtf2f1 | mm10_v2_chr17_-_57011271_57011326 | 0.25 | 2.6e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.6 | 25.8 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 6.6 | 39.7 | GO:1903056 | positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 6.4 | 19.1 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 5.7 | 17.0 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
| 5.6 | 33.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 5.0 | 10.1 | GO:0002159 | desmosome assembly(GO:0002159) |
| 4.7 | 51.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 4.6 | 18.5 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 4.0 | 8.0 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 3.7 | 11.2 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 3.5 | 17.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 3.5 | 10.4 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 3.4 | 10.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 3.3 | 10.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 3.2 | 51.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 3.0 | 9.0 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 2.9 | 14.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 2.8 | 11.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 2.7 | 27.2 | GO:0046959 | habituation(GO:0046959) |
| 2.6 | 13.0 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 2.5 | 7.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 2.3 | 9.4 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
| 2.2 | 9.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 2.2 | 8.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 2.2 | 6.5 | GO:0030070 | insulin processing(GO:0030070) |
| 2.2 | 6.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 2.1 | 8.6 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 2.1 | 6.4 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.1 | 8.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 2.1 | 18.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 2.1 | 8.2 | GO:0097393 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 2.0 | 6.1 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 2.0 | 8.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 2.0 | 5.9 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 1.9 | 7.8 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.8 | 5.5 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.8 | 16.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 1.8 | 7.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.8 | 5.4 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 1.8 | 5.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.8 | 1.8 | GO:1904908 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.7 | 8.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 1.7 | 6.9 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.7 | 8.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 1.7 | 1.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 1.6 | 6.6 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 1.6 | 4.9 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 1.6 | 6.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.6 | 1.6 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 1.6 | 7.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 1.5 | 7.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.5 | 7.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 1.5 | 5.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 1.4 | 4.3 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 1.4 | 2.9 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 1.4 | 1.4 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
| 1.4 | 4.3 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 1.4 | 2.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 1.4 | 4.2 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 1.4 | 17.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 1.4 | 2.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
| 1.4 | 8.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 1.4 | 8.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.4 | 4.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 1.4 | 6.9 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 1.4 | 5.4 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.4 | 21.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 1.4 | 2.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.3 | 11.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 1.3 | 5.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.3 | 3.8 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 1.3 | 2.5 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 1.3 | 5.1 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 1.3 | 6.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
| 1.2 | 23.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.2 | 19.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.2 | 4.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 1.2 | 6.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 1.2 | 10.5 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 1.2 | 3.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.2 | 5.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 1.1 | 10.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
| 1.1 | 19.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 1.1 | 5.6 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.1 | 3.3 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.1 | 2.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.1 | 17.2 | GO:0071625 | vocalization behavior(GO:0071625) |
| 1.1 | 7.4 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 1.1 | 3.2 | GO:0060596 | mammary placode formation(GO:0060596) |
| 1.0 | 3.1 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 1.0 | 14.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) asymmetric stem cell division(GO:0098722) |
| 1.0 | 3.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 1.0 | 3.1 | GO:0002586 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 1.0 | 5.0 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
| 1.0 | 3.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.0 | 6.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 1.0 | 4.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.0 | 16.9 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 1.0 | 2.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.0 | 4.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.0 | 6.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.9 | 2.8 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.9 | 1.8 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.9 | 0.9 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.9 | 3.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.9 | 2.7 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.9 | 4.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.9 | 1.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.9 | 6.9 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.9 | 6.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.9 | 1.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.9 | 2.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 0.8 | 4.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.8 | 7.6 | GO:0098907 | regulation of SA node cell action potential(GO:0098907) |
| 0.8 | 5.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.8 | 1.7 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.8 | 2.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.8 | 2.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 0.8 | 0.8 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.8 | 14.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.8 | 3.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.8 | 3.3 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.8 | 2.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.8 | 4.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.8 | 1.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.8 | 5.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.8 | 1.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.8 | 4.0 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
| 0.8 | 5.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.8 | 7.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.8 | 2.3 | GO:0035793 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.8 | 1.5 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.7 | 0.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.7 | 3.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.7 | 4.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 0.7 | 6.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.7 | 2.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.7 | 2.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.7 | 3.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.7 | 2.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.7 | 2.8 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 0.7 | 3.5 | GO:0051775 | response to redox state(GO:0051775) |
| 0.7 | 2.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.7 | 7.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.7 | 4.1 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.7 | 4.0 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.7 | 2.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.7 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.7 | 2.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.6 | 26.6 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.6 | 1.9 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.6 | 3.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.6 | 0.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.6 | 4.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 0.6 | 1.9 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.6 | 8.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.6 | 0.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
| 0.6 | 4.9 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.6 | 1.8 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.6 | 6.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.6 | 0.6 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.6 | 0.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.6 | 9.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.6 | 6.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.6 | 0.6 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.6 | 1.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.6 | 1.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.6 | 1.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 0.6 | 1.7 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.6 | 3.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.6 | 3.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.6 | 7.3 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.6 | 7.2 | GO:0036065 | fucosylation(GO:0036065) |
| 0.5 | 2.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 | 20.0 | GO:0048536 | spleen development(GO:0048536) |
| 0.5 | 1.6 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.5 | 6.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.5 | 5.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.5 | 2.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.5 | 1.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.5 | 2.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 | 1.5 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.5 | 2.0 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 0.5 | 1.5 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.5 | 3.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 0.5 | 1.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.5 | 1.5 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.5 | 2.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 | 2.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.5 | 4.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.5 | 4.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.5 | 1.4 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.5 | 3.3 | GO:0015862 | uridine transport(GO:0015862) |
| 0.5 | 1.4 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.5 | 1.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.5 | 12.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 | 0.5 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.5 | 3.3 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.5 | 3.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.5 | 1.4 | GO:1900365 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.5 | 3.2 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
| 0.5 | 2.3 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.5 | 2.8 | GO:1904587 | response to glycoprotein(GO:1904587) |
| 0.5 | 5.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.5 | 0.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 | 6.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.5 | 1.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.4 | 2.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.4 | 1.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.4 | 3.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.4 | 3.5 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.4 | 1.3 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.4 | 1.3 | GO:0010752 | signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) |
| 0.4 | 2.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.4 | 3.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.4 | 2.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.4 | 3.4 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 0.4 | 1.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.4 | 1.7 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.4 | 0.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.4 | 1.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.4 | 1.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.4 | 1.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.4 | 2.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.4 | 1.6 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.4 | 6.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.4 | 0.8 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.4 | 2.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.4 | 2.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 | 1.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.4 | 1.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.4 | 27.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.4 | 0.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
| 0.4 | 1.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.4 | 2.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.4 | 1.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.4 | 0.4 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 0.4 | 14.3 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.4 | 0.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.4 | 15.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.4 | 3.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.4 | 0.4 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.4 | 1.9 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.4 | 0.8 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.4 | 2.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.4 | 2.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.4 | 1.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.4 | 2.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.4 | 2.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.4 | 1.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.4 | 4.0 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.4 | 1.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.4 | 2.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.4 | 3.9 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.4 | 25.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.4 | 3.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.3 | 1.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.3 | 1.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.3 | 3.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.3 | 10.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 | 11.4 | GO:0043113 | receptor clustering(GO:0043113) |
| 0.3 | 1.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.3 | 1.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 | 1.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 | 2.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.3 | 2.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.3 | 0.7 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.3 | 0.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.3 | 1.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.3 | 2.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.3 | 2.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.3 | 4.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.3 | 3.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
| 0.3 | 7.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.3 | 7.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.3 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.3 | 1.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.3 | 2.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.3 | 0.9 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.3 | 0.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.3 | 2.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 | 9.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.3 | 2.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 0.6 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.3 | 0.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.3 | 0.6 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.3 | 2.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 2.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 | 0.9 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.3 | 3.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.3 | 0.9 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.3 | 4.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.3 | 1.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.3 | 3.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.3 | 3.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.3 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.3 | 3.9 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.3 | 2.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.3 | 2.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 1.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 | 0.8 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 | 1.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.3 | 1.3 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.3 | 1.9 | GO:0031424 | keratinization(GO:0031424) |
| 0.3 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.3 | 1.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.3 | 3.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.3 | 4.1 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 1.3 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.3 | 1.0 | GO:0061038 | gall bladder development(GO:0061010) uterus morphogenesis(GO:0061038) |
| 0.3 | 2.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.3 | 1.0 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.3 | 4.3 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
| 0.2 | 0.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.2 | 0.7 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 5.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.2 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.2 | 0.7 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.2 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 | 1.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 2.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 0.2 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
| 0.2 | 1.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.2 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.2 | 0.5 | GO:0031622 | positive regulation of fever generation(GO:0031622) positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.2 | 0.7 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.2 | 1.4 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
| 0.2 | 0.7 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 | 2.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.2 | 0.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.2 | 2.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 0.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 | 0.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.2 | 2.5 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.2 | 1.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 7.9 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.2 | 1.1 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 | 0.2 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
| 0.2 | 1.8 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 | 2.4 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.2 | 1.5 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.2 | 0.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 | 6.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 2.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 1.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 1.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 | 3.1 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.2 | 2.6 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.2 | 1.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 1.5 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 0.2 | 0.4 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.2 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 0.2 | 1.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 10.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.2 | 6.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 | 1.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 | 1.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 | 0.8 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 | 1.2 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.2 | 2.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.2 | 1.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 | 0.8 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.2 | 0.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 2.9 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.2 | 1.0 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 | 0.2 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.2 | 3.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 | 3.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 0.9 | GO:0090669 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) telomerase RNA stabilization(GO:0090669) |
| 0.2 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.2 | 0.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 | 3.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 1.1 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
| 0.2 | 0.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.2 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.2 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
| 0.2 | 1.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.2 | 0.4 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
| 0.2 | 0.7 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.2 | 0.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 | 1.4 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.2 | 0.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
| 0.2 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 1.1 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.2 | 0.7 | GO:0042447 | hormone catabolic process(GO:0042447) |
| 0.2 | 0.5 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 | 2.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 | 1.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.2 | 0.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.2 | 5.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.2 | 0.8 | GO:0044091 | membrane biogenesis(GO:0044091) |
| 0.2 | 0.3 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.2 | 3.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.2 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.2 | 0.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 4.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
| 0.2 | 0.3 | GO:2000016 | regulation of determination of dorsal identity(GO:2000015) negative regulation of determination of dorsal identity(GO:2000016) |
| 0.2 | 1.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 1.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 | 0.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.2 | 0.3 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.2 | 0.8 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 | 1.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.2 | 0.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 1.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 0.5 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
| 0.2 | 1.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 2.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 | 1.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 | 0.8 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 0.5 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.2 | 4.1 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.2 | 1.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 1.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 1.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 1.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 1.0 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 | 0.9 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.1 | 0.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.1 | 0.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 2.9 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 4.6 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 | 0.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.1 | 1.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 1.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 1.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.1 | 0.4 | GO:0010248 | B cell negative selection(GO:0002352) response to mycotoxin(GO:0010046) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 | 0.7 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.1 | 0.5 | GO:0001692 | histamine metabolic process(GO:0001692) imidazole-containing compound catabolic process(GO:0052805) |
| 0.1 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.1 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 | 0.5 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 1.9 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.1 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
| 0.1 | 2.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.1 | 1.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 | 0.5 | GO:0016358 | dendrite development(GO:0016358) |
| 0.1 | 1.4 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 | 1.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 2.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.1 | 1.3 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 1.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 1.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 | 0.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 | 0.8 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.1 | 0.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.1 | 0.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 1.4 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
| 0.1 | 1.0 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 3.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.5 | GO:0036093 | germ cell proliferation(GO:0036093) |
| 0.1 | 0.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 | 0.7 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.1 | 6.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.1 | 0.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 | 0.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
| 0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.1 | 0.2 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 | 0.8 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 1.6 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 | 0.4 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.1 | 1.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.1 | 0.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
| 0.1 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 0.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 0.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.2 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.1 | 4.3 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 2.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 0.4 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
| 0.1 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 1.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 1.6 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 0.1 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 0.1 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.1 | 3.9 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
| 0.1 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.2 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 | 7.9 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.1 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.1 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
| 0.1 | 0.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.1 | 7.3 | GO:0051101 | regulation of DNA binding(GO:0051101) |
| 0.1 | 0.4 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 2.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.8 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 1.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.1 | 0.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.1 | 1.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 0.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.1 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.7 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 | 3.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.1 | 0.8 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.1 | 0.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.1 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 3.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.1 | 1.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 | 2.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 1.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 0.5 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 0.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 0.9 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.1 | 0.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.1 | 1.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.1 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.1 | 2.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.1 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 2.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 1.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 0.2 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.1 | 1.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.4 | GO:0001996 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of heart rate by epinephrine(GO:0003065) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
| 0.1 | 0.5 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 1.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.1 | 1.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 | 0.6 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 | 0.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 0.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 0.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.2 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.1 | 0.5 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.1 | 0.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.1 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.0 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 | 0.7 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
| 0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.2 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.0 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.0 | 0.6 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 | 0.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 | 0.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.0 | 0.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 | 0.0 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.0 | 1.1 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 | 0.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.1 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 2.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.1 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 | 0.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 0.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 | 0.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.0 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
| 0.0 | 0.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.0 | 0.1 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 | 0.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 | 5.5 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
| 0.0 | 3.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.0 | 0.1 | GO:0010878 | cholesterol storage(GO:0010878) |
| 0.0 | 0.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 0.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.0 | 0.3 | GO:0048678 | response to axon injury(GO:0048678) |
| 0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.0 | 0.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.0 | 0.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
| 0.0 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.0 | 0.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 0.0 | 0.0 | GO:0034331 | cell junction maintenance(GO:0034331) |
| 0.0 | 0.1 | GO:0035814 | regulation of renal sodium excretion(GO:0035813) negative regulation of renal sodium excretion(GO:0035814) |
| 0.0 | 0.3 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.0 | 0.0 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.5 | GO:0036293 | response to decreased oxygen levels(GO:0036293) |
| 0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 0.2 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 | 0.2 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.0 | 0.3 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 | 0.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.0 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 | 0.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 0.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 0.2 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 0.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 1.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
| 0.0 | 0.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.6 | 33.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 4.4 | 21.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 3.8 | 7.6 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 3.1 | 9.3 | GO:0072534 | perineuronal net(GO:0072534) |
| 3.0 | 9.0 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 2.9 | 14.7 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 2.7 | 8.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 2.5 | 37.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 2.4 | 14.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 2.4 | 40.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 2.1 | 8.2 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
| 2.0 | 2.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 1.9 | 40.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.9 | 7.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 1.7 | 15.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 1.7 | 6.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 1.5 | 6.1 | GO:0031673 | H zone(GO:0031673) |
| 1.5 | 19.8 | GO:0030057 | desmosome(GO:0030057) |
| 1.5 | 17.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 1.4 | 4.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 1.4 | 1.4 | GO:0005921 | gap junction(GO:0005921) |
| 1.4 | 51.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 1.3 | 4.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.3 | 4.0 | GO:0098855 | HCN channel complex(GO:0098855) |
| 1.3 | 10.3 | GO:0005883 | neurofilament(GO:0005883) |
| 1.3 | 3.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.2 | 7.5 | GO:0008091 | spectrin(GO:0008091) |
| 1.2 | 3.7 | GO:0005940 | septin ring(GO:0005940) |
| 1.2 | 21.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 1.1 | 2.2 | GO:0097444 | spine apparatus(GO:0097444) |
| 1.0 | 33.9 | GO:0030673 | axolemma(GO:0030673) |
| 1.0 | 1.9 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.9 | 7.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.8 | 11.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.8 | 7.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.8 | 14.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.7 | 8.2 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.7 | 1.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.7 | 8.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.7 | 2.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.7 | 2.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.7 | 2.7 | GO:0090537 | CERF complex(GO:0090537) |
| 0.7 | 2.0 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.7 | 2.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 0.6 | 3.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.6 | 1.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 9.4 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.6 | 7.1 | GO:0043203 | axon hillock(GO:0043203) |
| 0.6 | 1.7 | GO:0043511 | inhibin complex(GO:0043511) |
| 0.5 | 23.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.5 | 3.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.5 | 8.7 | GO:0043196 | varicosity(GO:0043196) |
| 0.5 | 3.5 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.5 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.5 | 2.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.5 | 2.4 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.5 | 2.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.5 | 6.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.5 | 18.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.5 | 6.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.5 | 2.3 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.5 | 0.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 8.3 | GO:0031430 | M band(GO:0031430) |
| 0.4 | 10.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.4 | 1.3 | GO:0044304 | main axon(GO:0044304) |
| 0.4 | 1.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.4 | 93.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.4 | 3.3 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.4 | 2.8 | GO:0070695 | FHF complex(GO:0070695) |
| 0.4 | 2.0 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.4 | 3.5 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.4 | 1.9 | GO:0030891 | VCB complex(GO:0030891) |
| 0.4 | 7.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 0.4 | 1.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.4 | 1.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.4 | 4.3 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.4 | 1.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.4 | 6.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.4 | 1.4 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.3 | 4.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 2.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.3 | 2.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.3 | 1.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 2.6 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.3 | 6.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.3 | 1.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.3 | 2.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.3 | 7.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.3 | 2.0 | GO:0034464 | BBSome(GO:0034464) |
| 0.3 | 0.3 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
| 0.3 | 9.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.3 | 3.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.3 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
| 0.3 | 2.1 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.3 | 2.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 2.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.2 | 2.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 13.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 3.8 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 2.1 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.2 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 1.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 8.7 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 4.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 7.9 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.2 | 1.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.2 | 0.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.2 | 4.0 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.2 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 1.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.2 | 7.7 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.2 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.2 | 6.1 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 2.7 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.2 | 3.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
| 0.2 | 1.7 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.2 | 1.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.2 | 1.3 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 2.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 19.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 3.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 10.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.2 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.2 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.2 | 0.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 7.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.2 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.2 | 4.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.2 | 6.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 0.5 | GO:1904949 | ATPase complex(GO:1904949) |
| 0.2 | 10.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 1.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.2 | 0.9 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 1.9 | GO:0046930 | pore complex(GO:0046930) |
| 0.2 | 1.9 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.2 | 0.3 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.1 | 2.5 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.1 | 0.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 0.9 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 6.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.4 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.1 | 1.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 3.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.1 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 1.0 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 1.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 1.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 5.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 3.7 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 1.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 2.9 | GO:0030175 | filopodium(GO:0030175) |
| 0.1 | 2.9 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 22.5 | GO:0098794 | postsynapse(GO:0098794) |
| 0.1 | 0.9 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 1.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.1 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 18.5 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 5.5 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 2.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 7.4 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 2.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 2.0 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 1.3 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 0.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 6.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.1 | 3.7 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 2.2 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 1.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 3.6 | GO:0045202 | synapse(GO:0045202) |
| 0.1 | 8.2 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 2.2 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 3.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 1.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.1 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 1.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 5.5 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 0.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.1 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.2 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.1 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 3.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 1.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 3.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.0 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.0 | 0.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.0 | 1.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.0 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.0 | 0.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 5.3 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 1.6 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 4.8 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.0 | 0.5 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.0 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 1.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.0 | 0.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.0 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.0 | 0.2 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.0 | 1.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 1.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 1.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 12.7 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 0.7 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.1 | GO:0012506 | vesicle membrane(GO:0012506) |
| 0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.3 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
| 0.0 | 1.5 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 0.3 | GO:0030424 | axon(GO:0030424) |
| 0.0 | 11.5 | GO:0005794 | Golgi apparatus(GO:0005794) |
| 0.0 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.0 | 0.2 | GO:1990752 | microtubule plus-end(GO:0035371) microtubule end(GO:1990752) |
| 0.0 | 1.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.0 | 0.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.2 | 25.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 5.1 | 20.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 5.0 | 15.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 4.8 | 14.5 | GO:0034437 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
| 3.7 | 11.2 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 3.5 | 17.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 3.0 | 9.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 3.0 | 14.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 2.9 | 2.9 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 2.8 | 14.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 2.8 | 22.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 2.5 | 14.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 2.4 | 7.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 2.4 | 9.5 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
| 2.1 | 8.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 2.1 | 19.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 2.0 | 23.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 1.9 | 5.8 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 1.9 | 11.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 1.8 | 5.5 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 1.8 | 7.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 1.8 | 5.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 1.7 | 5.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 1.6 | 19.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 1.6 | 14.5 | GO:0030274 | LIM domain binding(GO:0030274) |
| 1.6 | 7.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.6 | 6.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 1.6 | 14.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 1.5 | 6.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 1.5 | 9.2 | GO:0043426 | MRF binding(GO:0043426) |
| 1.5 | 10.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.4 | 1.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 1.4 | 8.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 1.3 | 5.2 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 1.2 | 8.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 1.2 | 51.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 1.2 | 4.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 1.2 | 6.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 1.2 | 8.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 1.2 | 5.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 1.2 | 5.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 1.1 | 3.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 1.1 | 4.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.1 | 3.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.1 | 6.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 1.1 | 4.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.0 | 12.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 1.0 | 8.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 1.0 | 6.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.0 | 4.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 1.0 | 9.1 | GO:0034046 | poly(G) binding(GO:0034046) |
| 1.0 | 8.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 1.0 | 4.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 1.0 | 38.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 1.0 | 13.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 1.0 | 2.9 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
| 0.9 | 6.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) heterotrimeric G-protein binding(GO:0032795) |
| 0.9 | 2.7 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
| 0.9 | 4.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.9 | 2.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.9 | 6.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 0.8 | 6.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.8 | 5.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.8 | 4.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.8 | 8.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.8 | 11.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.8 | 14.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.8 | 7.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.8 | 3.0 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
| 0.7 | 4.5 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.7 | 5.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.7 | 4.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.7 | 28.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.7 | 10.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.7 | 2.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.7 | 10.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.7 | 1.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.7 | 6.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.6 | 10.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.6 | 3.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.6 | 3.8 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.6 | 8.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.6 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.6 | 3.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.6 | 1.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.6 | 2.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.6 | 5.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.6 | 1.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.6 | 2.4 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 0.6 | 5.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.6 | 5.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.6 | 4.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.6 | 2.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
| 0.5 | 2.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.5 | 16.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.5 | 7.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.5 | 4.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.5 | 3.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.5 | 14.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.5 | 1.6 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.5 | 3.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.5 | 5.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.5 | 2.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.5 | 3.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.5 | 9.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.5 | 2.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.5 | 1.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.5 | 6.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.5 | 8.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.5 | 2.3 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.5 | 1.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.4 | 8.3 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 8.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.4 | 1.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.4 | 1.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.4 | 0.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.4 | 1.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.4 | 4.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.4 | 1.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.4 | 3.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.4 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.4 | 1.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.4 | 2.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
| 0.4 | 6.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.4 | 1.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.4 | 3.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) |
| 0.4 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.4 | 1.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.4 | 1.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.4 | 11.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.4 | 1.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.4 | 1.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.4 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.4 | 2.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.4 | 4.7 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.4 | 3.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 0.4 | 5.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.4 | 1.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.4 | 4.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.3 | 3.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.3 | 10.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 1.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.3 | 1.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.3 | 1.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.3 | 1.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.3 | 18.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.3 | 9.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.3 | 11.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.3 | 2.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.3 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.3 | 1.8 | GO:0045340 | mercury ion binding(GO:0045340) |
| 0.3 | 9.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.3 | 2.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.3 | 3.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.3 | 1.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.3 | 0.8 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.3 | 1.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.3 | 1.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.3 | 5.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.3 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.3 | 5.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.3 | 2.5 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.3 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.3 | 1.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.7 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.2 | 1.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.2 | 2.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 3.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 1.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.2 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 0.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.2 | 12.7 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 4.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 4.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.2 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.2 | 1.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.2 | 0.9 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.2 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.2 | 4.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 35.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.2 | 2.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.2 | 1.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.2 | 1.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.2 | 17.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.2 | 1.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 1.5 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 0.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.2 | 0.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 0.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.2 | 2.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.2 | 2.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 8.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 4.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 2.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
| 0.2 | 3.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 1.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 18.9 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.2 | 2.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.2 | 3.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 1.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 1.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 7.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 6.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 3.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.2 | 4.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 4.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 0.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.2 | 0.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) fructose-6-phosphate binding(GO:0070095) |
| 0.2 | 0.7 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
| 0.2 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 0.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.2 | 0.2 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 0.2 | 3.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.2 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.2 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.2 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 3.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.2 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.2 | 7.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.2 | 0.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.2 | 1.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 2.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 4.2 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 1.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 2.4 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 3.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 2.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 1.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.1 | 1.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 1.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.1 | 1.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 4.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 0.1 | 25.9 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 2.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 1.3 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.1 | 1.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.1 | 0.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.1 | 3.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 1.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 3.1 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
| 0.1 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.1 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 2.2 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.1 | 1.2 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
| 0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 1.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 2.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 3.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 10.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 5.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.1 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 7.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 0.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.1 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.1 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 2.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 0.6 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 2.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.3 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.1 | 0.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 1.3 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.1 | 10.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.1 | 0.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.1 | 0.3 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.1 | 0.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
| 0.1 | 0.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 3.3 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 0.1 | 3.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 1.4 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 18.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 2.0 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 1.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 2.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 4.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.1 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 0.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.1 | 2.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.1 | 3.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.1 | 3.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 2.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 1.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.1 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 24.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.1 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.0 | 0.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.0 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.0 | 1.0 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.0 | 0.7 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.0 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 3.9 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.0 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.0 | 0.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.0 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.0 | 0.2 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 2.1 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.2 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 0.0 | 0.5 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.0 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.0 | 0.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.0 | 0.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.0 | 1.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.0 | 4.2 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.0 | 0.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.0 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.0 | 0.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.0 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 2.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.8 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.0 | 0.9 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.0 | 0.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.0 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.0 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 27.9 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.8 | 47.9 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.8 | 14.9 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.6 | 15.5 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.5 | 7.5 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 0.5 | 13.1 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.5 | 42.5 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.5 | 17.2 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.5 | 12.0 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.5 | 1.4 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.5 | 10.4 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.4 | 22.0 | PID_SHP2_PATHWAY | SHP2 signaling |
| 0.4 | 7.1 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.4 | 13.1 | PID_RAS_PATHWAY | Regulation of Ras family activation |
| 0.4 | 12.0 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.4 | 8.0 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.4 | 8.0 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.4 | 12.9 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.4 | 1.4 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.4 | 3.2 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.3 | 4.9 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 0.3 | 4.1 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.3 | 23.7 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
| 0.3 | 1.6 | PID_S1P_S1P3_PATHWAY | S1P3 pathway |
| 0.3 | 2.5 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.3 | 7.9 | PID_LYSOPHOSPHOLIPID_PATHWAY | LPA receptor mediated events |
| 0.3 | 10.3 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 4.5 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
| 0.3 | 2.6 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.3 | 10.5 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.3 | 4.7 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 3.7 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.2 | 11.0 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.2 | 2.8 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.2 | 1.2 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
| 0.2 | 2.0 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.2 | 3.2 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 4.6 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 5.0 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.2 | 5.3 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
| 0.2 | 4.2 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.2 | 2.5 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.2 | 1.6 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.2 | 1.7 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
| 0.2 | 2.1 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 2.4 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.2 | 2.3 | PID_CD40_PATHWAY | CD40/CD40L signaling |
| 0.1 | 1.0 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 3.8 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.1 | 1.0 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 1.6 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 1.5 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.1 | 3.5 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 2.7 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 0.7 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 2.0 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.1 | 0.4 | PID_ENDOTHELIN_PATHWAY | Endothelins |
| 0.1 | 0.7 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.1 | 0.2 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
| 0.1 | 1.2 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 0.4 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 0.4 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 0.8 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.1 | 0.4 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.5 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.1 | 0.6 | PID_INSULIN_PATHWAY | Insulin Pathway |
| 0.1 | 0.7 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 3.2 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.1 | 0.3 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 0.2 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 0.6 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
| 0.0 | 0.9 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 0.1 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.7 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.3 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 3.4 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.8 | PID_CDC42_PATHWAY | CDC42 signaling events |
| 0.0 | 0.2 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.0 | 0.4 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 44.0 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 2.4 | 7.1 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 1.8 | 17.9 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 1.7 | 17.0 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 1.7 | 40.5 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 1.3 | 16.9 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 1.2 | 7.2 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 1.2 | 3.5 | REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 1.0 | 7.2 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 1.0 | 12.9 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.9 | 2.8 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.8 | 15.7 | REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.8 | 6.3 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 0.7 | 0.7 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.7 | 9.7 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.6 | 6.4 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.6 | 8.5 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.6 | 1.1 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.5 | 7.0 | REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.5 | 21.6 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.5 | 5.3 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.5 | 5.9 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.4 | 2.2 | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.4 | 3.0 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.4 | 8.9 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 11.4 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.4 | 6.7 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.4 | 1.7 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 2.9 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.4 | 13.3 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.4 | 7.1 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.4 | 6.4 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.4 | 2.9 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.4 | 11.3 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.4 | 9.3 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.4 | 0.7 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.3 | 12.2 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.3 | 6.4 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.3 | 3.0 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.3 | 7.2 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.3 | 4.2 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.3 | 4.5 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.3 | 2.7 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 6.9 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 2.5 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.3 | 0.5 | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.3 | 1.3 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.3 | 9.2 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.3 | 7.9 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.2 | 1.5 | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.2 | 4.4 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.2 | 9.6 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
| 0.2 | 2.4 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.2 | 5.1 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 2.7 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 5.0 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.2 | 5.6 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 3.2 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 2.0 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 2.1 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.2 | 6.8 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.2 | 1.7 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 4.7 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 6.3 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 5.1 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 4.9 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 3.4 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.1 | 9.4 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 0.3 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.1 | 1.7 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 5.6 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 2.4 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.1 | 3.6 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 2.1 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 3.0 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 1.8 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 1.4 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 4.2 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 4.3 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 0.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 0.4 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.1 | 3.5 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 2.0 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 2.0 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 3.0 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.1 | 0.4 | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
| 0.1 | 1.3 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 2.3 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
| 0.1 | 4.1 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.7 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 1.0 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 0.5 | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.1 | 0.5 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 0.4 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 1.1 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 0.5 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 1.4 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 0.6 | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_ | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 2.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 1.4 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 6.4 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 1.1 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 2.6 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 0.9 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 2.5 | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.1 | 0.8 | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.1 | 0.4 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 1.6 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 1.0 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.5 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 0.1 | 0.2 | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.1 | 1.8 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 3.2 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 0.7 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 1.2 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 0.3 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 1.2 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 1.0 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.6 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.5 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.5 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.9 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 0.4 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
| 0.0 | 2.0 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.7 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.7 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 1.2 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.1 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 0.4 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.6 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.8 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.6 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 1.4 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.0 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.1 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 0.0 | 0.5 | REACTOME_SPHINGOLIPID_METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.0 | 0.5 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.2 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.1 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 1.4 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.1 | REACTOME_SHC_MEDIATED_CASCADE | Genes involved in SHC-mediated cascade |
| 0.0 | 0.1 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.6 | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.0 | 0.3 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 0.3 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.3 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.0 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
|
|
|